v3.25.4
Intangible Assets and Goodwill
 6 Months Ended
Dec. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets and Goodwill INTANGIBLE ASSETS AND GOODWILL
Intangible assets—The carrying amounts, accumulated amortization, net carrying value, and weighted average remaining life of our definite-lived amortizable intangible assets are presented below (dollars in thousands, useful life in years):

December 31, 2025June 30, 2025
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying Amount
Impairment Charges
Accumulated AmortizationNet Carrying Amount
Customer relationships$1,423 $(1,400)$23 $17,492 $(4,209)$(13,252)$31 
Trade name— — — 2,680 — (2,680)— 
Proprietary software4,342 (2,968)1,374 4,342 — (2,418)1,924 
Non-compete agreements100 (93)7 100 — (82)18 
Total intangible assets$5,865 $(4,461)$1,404 $24,614 $(4,209)$(18,432)$1,973 

The Company's intangible assets include those long-lived intangible assets acquired as part of acquisitions. The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. There were no impairment triggers identified with respect to the Company’s long-lived assets during the three and six months ended December 31, 2025 and 2024.

For the three months ended December 31, 2025 and 2024, amortization expense related to intangible assets totaled $0.3 million and $1.0 million, respectively, and $0.6 million and $2.1 million for the six months ended December 31, 2025 and 2024, respectively, recorded in selling, general and administrative expense in the condensed consolidated statements of comprehensive income. The weighted-average remaining useful life of intangible assets was 1.3 years and 1.8 years as of December 31, 2025 and June 30, 2025, respectively.

As of December 31, 2025, expected amortization expense in future fiscal periods were as follows (in thousands):
Proprietary SoftwareNon-compete agreementsCustomer relationshipsTotal
Remainder of 2026$550 $7 $9 $566 
2027824 — 14 838 
Total$1,374 $7 $23 $1,404 

Goodwill—The Company recorded as goodwill the excess of the purchase price over the estimated fair values of identifiable assets and liabilities acquired as part of prior period acquisitions. Goodwill is assigned to reporting units that are expected to benefit from the synergies of the business combination as of the acquisition date and becomes identified with that reporting unit in its entirety. As such, the reporting unit as a whole supports the recovery of its goodwill. As of December 31, 2025, the Company’s goodwill balance of $29.4 million, all of which is assigned to the Healthcare Services reporting unit and reportable segment, was related to the acquisitions of Express Meds, Simple Meds, and SelectPatient Management.

The Company performs its annual goodwill impairment testing as of April 1, or more frequently if it believes that indicators of impairment exist. During the three and six months ended December 31, 2025 and 2024, there were no indicators of impairment.